Les publications contenues dans cette section d’archives sont fournies à des fins historiques uniquement. Les opinions présentées dans les publications sont celles de leurs auteurs et ne reflètent pas les opinions de NOXXON. NOXXON rejette toute obligation de mise à jour ou de correction des informations contenues dans ces articles.

Maasch C, Vater A, Buchner K, Purschke WG, Eulberg D, Vonhoff S, Klussmann S.
Polyethylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.
J. Biol. Chem. 2010, Vol. 285(51), 40012-8.
view PubMed abstract on ncbi.nlm.nih.gov

Sayyed, S. G., Gaikwad, A. B., Lichtnekert, J., Kulkarni, O. P., Eulberg, D., Klussmann, S., Tikoo, K. & Anders, H.-J.
Progessive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.
Nephrol. Dial. Transplant. 2010, Vol. 25(6), 1811-7.
view PubMed abstract on ncbi.nlm.nih.gov

Sayyed, S. G., Hägele, H., Kulkarni, O. P., Endlich, K., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J.
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.
Diabetologia 2009, Vol. 52(11), 2445-2454.
view PubMed abstract on ncbi.nlm.nih.gov

Schlesinger, J., Fischer, C., Koezle, I., Vonhoff, S., Klussmann, S., Bergmann, R., Pietzsch, H.-J. & Steinbach, J.
Radiosynthesis of new [90Y]-DOTA-based maleimide reagents suitable for the prelabeling of thiol-bearing L-oligonucleotides and peptides.
Bioconj. Chem. 2009, Vol. 20(7), 1340-1348.
view PubMed abstract on ncbi.nlm.nih.gov

Clauss, S., Gross, O., Kulkarni, O., Avila-Ferrufino, A., Radomska, E., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J.
Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy.
J. Pathol. 2009, Vol. 218(1), 40-47.
view PubMed abstract on ncbi.nlm.nih.gov

Kulkarni, O., Eulberg, D., Selve, N., Zöllner, S., Allam, R., Pawar, R. D., Pfeiffer, S., Segerer, S., Klussmann, S., & Anders, H.-J.
Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
J. Pharmacol. Exp. Ther. 2009, Vol. 328(2), 371-377.
view PubMed abstract on ncbi.nlm.nih.gov